Author: Piers Townley
-
Everest in the Alps presents a mountainous training challenge for Phil Spencer
TV presenter Phil Spencer prepares to take on the Everest in the Alps expedition to raise funds for life-saving research into childhood brain tumours
-
New phase 2 clinical trial testing immunotherapy drug announced
A phase 2 clinical trial testing an immunotherapy drug called ipilimumab to treat patients with glioblastomas has been announced in the United Kingdom
-
Pioneering fundraising as we head in to 2018
Proud to announce our innovative charity partnership with Sulla Investment
-
An evening with our researchers
On 6 March, we’re hosting a unique opportunity to get your research questions answered as our Scientific Advisory Board comes together from across the globe
-
Is anti-angiogenic therapy to treat glioblastomas a viable option?
Results of two phase 2 clinical trials testing cabozantinib suggest that anti-angiogenic therapy could be used to treat glioblastomas
-
Better services needed for children with life-limiting illnesses
We were proud to stand alongside some of our inspirational supporters at the House of Commons today to press for better UK-wide services for children with life-limiting illnesses
-
Phil Spencer takes on the second Everest in the Alps challenge
Channel 4 presenter of Location, Location, Location and Love it or List It to join charity’s epic ski tour challenge in Verbier, Switzerland
-
Elena Hardy, a ballet dancer and mum of two, warns of the risks of ignoring brain tumour symptoms
Elena had been suffering excruciating headaches for over a year but it was one Tuesday morning in May 2015 that she took action
-
Simon Kindleysides, a paralysed dad of three, to take on the London Marathon in an exo-suit
Already an accomplished singer and guest judge on the new Saturday BBC1 show, All Together Now, Simon, has now set his eyes on one of his biggest challenges yet; to take on the London Marathon wearing the revolutionary ReWalk exo-suit
-
Combination therapy could significantly improve glioblastoma survival rates
Researchers at Massachusetts General Hospital prepare to launch a phase 1 clinical trial to test the combination therapy of hydroxyurea and temozolomide (TMZ)
-
Our research update into glioblastoma, adaptive trials, and the ‘pink drink’
Our Research Engagement Manager Becky Birch, outlines developments highlighted by Tessa Jowell’s debate
-
Baroness Jowell calls for better cancer treatment in House of Lords debate
Former Cabinet minister Tessa Jowell led a debate in the House of Lords yesterday where she asked the Government to support her call for an acceleration of new cancer treatments and improvements in patient care
-
Tessa Jowell’s House of Lords Debate
Our Policy & Public Affairs Manager Cameron Miller, reflects of Tessa Jowell’s moving House of Lords debate today
-
What is an adaptive clinical trial?
In her interview on the Today programme, Tessa Jowell talked about adaptive clinical trials. Find out more
-
Tessa Jowell highlights the devastating effect of her brain tumour diagnosis
Former cabinet Minister Tessa Jowell appeared on the Today programme this morning talking about her brain tumour diagnosis and need for more research into the disease
-
Tessa Jowell to lead high-profile cancer debate
Former cabinet Minister Tessa Jowell will speak out for the first time later this week about her brain tumour diagnosis as she spearheads a public debate about cancer treatments and life expectancy
-
Study reveals cancer therapy can also drive tumour regrowth
A study involving multiple institutions in the United States reported that conventional cancer therapy initiates a series of events that encourage living cancer cells to grow and develop new tumours
-
Charity ambassador living with a brain tumour to take on the London marathon
Our Young Ambassador Chandos Green is set to take on the challenge of his life
-
Launching our Big Bandana Bake
This March, we are aiming to raise £150,000 to fund a life-saving research project for over two years
-
Targeting the body’s internal clock to treat glioblastoma
Researchers have discovered that the circadian rhythm, also known as a person’s ‘internal clock’, could hold the answers to develop new therapies for glioblastoma
-
Launching our data-sharing project in quest for brain tumour cure
Pioneering web-app will help patients and researchers
-
Announcing our co-funding grants with Worldwide Cancer Research
Scotland-based charity, Worldwide Cancer Research, has formed a unique partnership with us to fund two outstanding scientists’ work on brain cancer
-
Our funded research shows blood-brain barrier success
Research funded by The Brain Tumour Charity has proved for the first time that a naturally-occurring virus can cross the blood-brain barrier in humans and attack tumour cells in the brain
-
Our Policy teams New Year’s resolutions
Our Policy & Public Affairs Manager Cameron Miller outlines why 2017 was a fantastic year for the Policy Team at The Brain Tumour Charity